Main Article Content




Article Details

Public Law


Larsen, G., & Lawson, R. (2013). Consumer rights: An assessment of justice. Journal of business ethics, 112(3), 515-528.

Devenney, J., & Kenny, M. (Eds.). (2012). European consumer protection: theory and practice. Cambridge University Press.

Schrader, U. (2007). The moral responsibility of consumers as citizens. International Journal of Innovation and Sustainable Development, 2(1), 79-96.

Bárd, P., Carrera, S., Guild, E., & Kochenov, D. (2016). An EU mechanism on democracy, the rule of law and fundamental rights. CEPS Paper in Liberty and Security in Europe.

LeBlanc, C. (2018). Land of the Free Market: US Companies Continue to Enjoy Greater Legal Protection than Consumers. Suffolk J. Trial & App. Advoc., 24, 94.

Aziz, M., Ghofur, A., & Hidayati, N. N. (2021). Regulation on the Implementation of Halal Product Assurance in Indonesia: Statute Approaches Study. Ulul Albab: Jurnal Studi dan Penelitian Hukum Islam, 4(2), 209-230.

Bartley, T. (2018). Rules without rights: Land, labor, and private authority in the global economy. Oxford University Press.

Chandra, T. (2019). Non-Litigation Process Land Dispute Settlement for Legal Certainty. Substantive Justice International Journal of Law, 2(2), 177-194.

Wantu, F. M., & Sarson, M. T. Z. (2020). Legal Protection of Women as Victim of Domestic Violence. Indonesian Journal of Advocacy and Legal Services, 1(2), 243-258.

Dinanti, D., Sakti, M., Irfani, I. P., & Pramita, S. A. (2020). Politics of Law for the Protection of Debtors as Consumers in Fintech based Loaning Services. Unnes Law Journal: Jurnal Hukum Universitas Negeri Semarang, 6(2), 427-444.

Hedegaard, J. S., & Wrbka, S. (2016). The notion of consumer under EU legislation and EU case law: Between the poles of legal certainty and flexibility. In Legal Certainty in a Contemporary Context (pp. 69-88). Springer, Singapore.

Pager, S. (2003). Strictness vs. Discretion: The European Court of Justice's Variable Vision of Gender Equality. The American Journal of Comparative Law, 51(3), 553-610.

Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., ... & Steinmetz, N. F. (2020). COVID-19 vaccine development and a potential nanomaterial path forward. Nature nanotechnology, 15(8), 646-655.

Foged, C. (2011). Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Therapeutic delivery, 2(8), 1057-1077.

Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., & Shapiro, M. (2018). Understanding modern-day vaccines: what you need to know. Annals of medicine, 50(2), 110-120.

Doytchinova, I. A., & Flower, D. R. (2007). VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC bioinformatics, 8(1), 1-7.

Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature reviews. Drug discovery, 19(5), 305-306.

Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020). Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine, 26, 100495.

Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020). Immunological considerations for COVID-19 vaccine strategies. Nature Reviews Immunology, 20(10), 615-632.

Samuel, R. Flu Shot Season, COVID-19 and How Pharmacies are Bracing for Impact.

Kłoskowicz, M., & Kasperkiewicz, K. (2020). Człowiek kontra wirusy. No Limits, (2), 28-29.

Peeples, L. (2020). News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine. Proceedings of the National Academy of Sciences, 117(15), 8218-8221.

Iboi, E. A., Ngonghala, C. N., & Gumel, A. B. (2020). Will an imperfect vaccine curtail the COVID-19 pandemic in the US?. Infectious Disease Modelling, 5, 510-524.

Kalla, I. S., & Laher, A. (2020). COVID-19: the concept of herd immunity–is it a strategy for South Africa?. Wits Journal of Clinical Medicine, 2(Si1), 39-42.

Riad, A., Schünemann, H., Attia, S., Peričić, T. P., Žuljević, M. F., Jürisson, M., ... & Klugar, M. (2021). COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects. International journal of environmental research and public health, 18(15), 7859.

Pangarsa, E. A., Setiawan, B., Santosa, S., Naibaho, R. M., Rizky, D., Suyono, S., ... & Suharti, C. (2021). COVID-19 vaccination in patients with cancer: Position paper from the Indonesian Society of Hematology and Medical Oncology (ISHMO) of Semarang. Bali Medical Journal, 10(1).

Mazzoni, A., Di Lauria, N., Maggi, L., Salvati, L., Vanni, A., Capone, M., ... & Annunziato, F. (2021). First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in recovered COVID-19 subjects. The Journal of Clinical Investigation.

Tuite, A. R., Zhu, L., Fisman, D. N., & Salomon, J. A. (2021). Alternative dose allocation strategies to increase benefits from constrained COVID-19 vaccine supply. Annals of internal medicine, 174(4), 570-572.

Zuin, M., Rigatelli, G., Zuliani, G., Rigatelli, A., Mazza, A., & Roncon, L. (2020). Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. The Journal of infection, 81(1), e84.

Abi Jaoude, J., Kouzy, R., El Alam, M. B., Subbiah, V., Taniguchi, C. M., Ludmir, E. B., & Lin, T. A. (2020, October). Exclusion of Older Adults in COVID-19 Clinical Trials. In Mayo Clinic Proceedings (Vol. 95, No. 10, p. 2293). Elsevier.

Price, D. N., Kunda, N. K., McBride, A. A., & Muttil, P. (2016). Vaccine preparation: past, present, and future. Delivery Systems for Tuberculosis Prevention and Treatment, 69.

Petousis-Harris, H. (2020). Assessing the safety of COVID-19 vaccines: a primer. Drug safety, 43(12), 1205-1210.

Scarabel, L., Guardascione, M., Dal Bo, M., & Toffoli, G. (2021). Pharmacological strategies to prevent SARS-CoV-2 infection and to treat the early phases of COVID-19 disease. International Journal of Infectious Diseases.

Sumas, S. (2021). New Normal Workplace during the Covid-19 Pandemic in Indonesia. Jurnal Bina Ketenagakerjaan, 2(1), 25-41.

Mackenzie, G. A., Osei, I., Salaudeen, R., Secka, O., D’Alessandro, U., Clarke, E., ... & Mulholland, K. (2021). Pneumococcal Conjugate Vaccination Schedules Acquisition, Immunogenicity and Pneumococcal Conjugate and Yellow Fever Vaccine Co-Administration Study.

Sudikno Mertokusumo, (1984), Bunga Rampai Ilmu Hukum, Yogyakarta : Liberty.

Philipus M. Hardjono, (1987), Perlindungan Hukum Bagi Rakyat Indoensia, Surabaya : PT. Bina Ilmu.

Hulman Panjaitan, (2021), Hukum Perlidungan Konsumen, Jakarta : Kencana.

Rafael La Porta, Journal of Financial Economics No. 58, Oktober 1999.

Buku Ajar Imunisasi, Kementerian Kesehatan RI, GAVI The Vaccine Alliance. 2014. Konsep Dasar Imunisasi.

Hilbe, J.M., (2015 ) Practical Guide to Logistic Regression, Taylor & Francis.

Hosmer, D.W. dan Stanley Lemeshow, Rodney X. Sturdivant, ( 2013) Applied Ligistic Regression, Wiley.

Garson, G.D., (2016),Logistic Regression: Binary & Multinomial: 2016 Edition (Statistical Associates "Blue Book" Series Book 2) Kindle Edition

WHO.2020. Vaccines and immunization : what is vaccination.

CDC. 2020. Understanding How COVID-19 Vaccines Work. Centers for Disease Control and Prevention.Available on: work.html#:~:text=Once%20vaccinated%2C%20our%20immune%20system,recognize%20and%20fight%20the%20virus.

Komite Penanganan Covid-19 dan Pemulihan Ekonomi Nasional. Paket Advokasi Vaksin Covid-19 Lindungi Diri, Lindungi Negeri. Kementrian Kesehatan Republik Indonesia, 2020.

Kementerian Kesehatan RI. 2020. Seputar Pelaksanaan Vaksinasi COVID-19.

PAPDI. Rekomendasi PAPDI tentang Vaksinasi COVID-19. 18 Januari 2021. Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia.

Kuntoro Harimurti. Penapisan untuk Vaksinasi COVID-19. 13 Februari 2021. Kementerian Kesehatan Republik Indonesia.